“…Also, this cancer heterogeneity imparts clinical relevance as clonal diversity within the cancer influences metastatic potential, therapeutic response and patient survival [6] . These clonal and subclonal cancer diversities and dynamics are thought to be influenced by cellular heterotypic stimuli, including hypoxia, spatial proximity, clonal frequency, and cellular plasticity [7] , [8] , [9] . Therefore, characterising and identifying the mechanisms underlying this non-genetic heterogeneity is also of fundamental clinical importance for guiding treatment modalities and avoiding tumour recurrence.…”